// App-Quantinova.ai

: Early Adverse Outcomes of Liver Allografts from Donors with COVID Vaccine Induced Thrombosis and Thrombocytopenia Syndrome

Researchers

Presenter

  • A. Hann

Principal Investigators

  • H. Hartog

  • W. Lester

  • P. Trivedi

  • K. Sharif

  • O. Cain

  • D. Neil

  • J. Isaac

  • D. Mirza

  • T. Perera

Medical Centers

  • Queen Elizabeth Hospital, The Liver Unit, United Kingdom

  • Queen Elizabeth Hospital, Department of Cellular Pathology, United Kingdom

  • Birmingham Childrens Hospital, The Liver Unit, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved